Dr. Zohar Dotan
A specialist in surgical treatment of prostate and testicular tumors, kidney cancer and urinary tract cancers using minimally invasive endoscopic surgery, including highly complex transurethral techniques.
Dr. Zohar Dotan is a doctor of medical sciences and one of Israel's best uro-oncologists, whose name is known far beyond the country, an expert in differential diagnosis of urogenital tumors and a recognized specialist in modern treatment of all forms of urogenital cancer. Dr. Dotan masterfully employs advanced areas of endoscopic oncologic surgery, including the latest techniques for surgical treatment of tumors of the prostate, bladder, testicles and urinary tract by progressive minimally invasive methods.
Dr. Zohar Dotan received his medical education and diploma at Tel Aviv University. He then specialized in various areas of surgery and in general and surgical urology at the university clinic at Chaim Sheba Medical Center. He continued studying urogenital tumors and mastering modern approaches to their effective treatment at the clinical base of the Hebrew University in Jerusalem, Kaplan Medical Center, and then trained in uro-oncology and endoscopic urological surgery at Memorial Sloan Kettering Cancer Center (New York, USA). Having become a qualified specialist in uro-oncology and urological surgery, Dr. Dotan returned to Sheba as a leading specialist in the urology department. He served in the Israel Defense Forces and speaks Hebrew and English.
Today Dr. Zohar Dotan is one of the best-known uro-oncologists in the country, with a reputation as a specialist of the highest professional qualification. He heads the uro-oncology department at Sheba Medical Center and is among the five most sought-after urological surgeons practicing at the private Assuta Medical Center. He heads the Israeli Association of Uro-Oncologists, belongs to several highly authoritative specialized societies in Europe and the USA, and has published more than 50 scientific papers on modern ways to solve oncological problems of the urogenital sphere.
Alongside extensive clinical practice, Dr. Dotan conducts intensive research aimed at improving the diagnosis and treatment of all types of urogenital cancer, in particular participating in developing the latest methods for treating prostate cancer based on minimally invasive technologies, and studying the use of molecular tumor markers in early diagnosis and staging of urogenital cancer. For special achievements in oncology, Dr. Dotan has three times received an award from the American Society of Clinical Oncology.
Dr. Zohar Dotan is competent in modern methods of diagnosing and treating cancer of the genitourinary system, including:
- surgical treatment of prostate and kidney tumors using MIT (minimal invasive technology);
- treatment of bladder cancer and testicular cancer using advanced methods of endoscopic urological surgery;
- expert assessment of tumor staging and development of the optimal treatment algorithm;
- evaluation of surgical treatment results and development of personal treatment and rehabilitation plans.
Dr. Dotan masterfully applies progressive transurethral and laparoscopic methods of urological surgery, which increases their effectiveness several times while significantly reducing postoperative risks.